Overexpression of eIF3e is correlated with colon tumor development and poor prognosis

Zhi Li; Shengtao Lin; Tao Jiang; Jingtao Wang; Huijun Lu; Huamei Tang; Mujian Teng; Junwei Fan
November 2014
International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 10, p6462
Academic Journal
EIF3e is a component of the eukaryotic translation initiation factor 3 (eIF-3) complexes, which is an essential factor for initiation of protein synthesis in mammalian cells. Translational control plays key roles in the complex mechanism of cancer development and progression. However, the clinical significance of eIF3e in colon cancer remains to be elucidated. We analyzed the eIF3e expression in a tissue microarray (TMA), which contained 173 colon cancer tissues paired with adjacent normal mucosa and lymph node metastasis. The expression of eIF3e was significantly elevated in colon cancer tissues in comparison with those in adjacent normal mucosa (P < 0.001) and lymph node metastasis (P < 0.001). The high expression of eIF3e in colon cancer was significantly correlated with tumor size (P < 0.001), lymph node involvement (P < 0.001), distant metastasis (P < 0.001), clinical stage (P < 0.001), histopathologic classification (P < 0.001), and vessel invasion (P = 0.036). Univariate and multivariate analysis revealed that eIF3e is an independent prognosis factor for overall survival and disease-free survival in colon cancer. Down-regulation of eIF3e in vitro inhibited colon cancer cell proliferation, clonality and promoted cell apoptosis. Taken together, high eIF3e expression may contribute to tumor progression and predict poor prognosis in colon cancer.


Related Articles

  • Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer. Wang Likui; Wang Hong; Zhang Shuwen; Likui, Wang; Hong, Wang; Shuwen, Zhang // Journal of Gastrointestinal Surgery;Jan2010, Vol. 14 Issue 1, p74 

    Objective: Osteopontin (OPN) is a phosphorylated glycoprotein which is associated with tumor progression, development, and metastasis. Recently, it has been reported that OPN is highly upregulated in a variety of human malignancies. The aim of this study is to investigate the...

  • Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Konishu, Tsuyoshi; Watanabe, Toshiaki; Kishimoto, Junji; Kotake, Kenjiro; Muto, Tetsuichiro; Nagawa, Hirokazu // Gut;Jun2007, Vol. 56 Issue 6, p863 

    Background: Colorectal carcinoids are often described as low-grade malignant. However, no study has compared the survival between patients with colorectal carcinoids and those with carcinomas, in a large series. In addition, no global consensus has been established on the crucial determinants of...

  • Kolorektal Kanserlerde Lenf Nodu Oranının Prognostik Önemi. Özdemir, Yavuz; Özdemir, Sevim; Filiz, Ali İlker; Sücüllü, İlker; Kurt, Yavuz; Yıldız, Mehmet // Balkan Medical Journal;Mar2011, Vol. 28 Issue 1, p86 

    Objective: This study was designed to assess the prognostic value of lymph node ratio (LNR) in patients with nonmetastatic colorectal cancer treated with radical resection. Material and Methods: The characteristic and pathologic parameters of 280 patients operated on for nonmetastatic colorectal...

  • The Impact of the Ratio of Positive to Total Lymph Nodes Examined and Outcome in Colorectal Cancer. NG, MELODY; ROY-CHOWDHURY, SHARMILA; LUM, SHARON S.; MORGAN, JOHN W.; WONG, JAN H. // American Surgeon;Oct2009, Vol. 75 Issue 10, p873 

    We sought to examine the significance of the number of nodes examined in node-positive colorectal cancer. Between January 1, 1994, and December 31, 2003, 7192 patients with colorectal cancer underwent potentially curative resection in Region 5 of the California Cancer Registry. Of these...

  • Prognostic factors in patients with synchronous peritoneal carcinomatosis (PC) caused by a primary cancer of the colon. Sadahiro, Sotaro; Suzuki, Toshiyuki; Maeda, Yuji; Tanaka, Akira; Makuuchi, Hiroyasu; Kamijo, Akemi; Haruki, Yasuo; Murayama, Chieko // Journal of Gastrointestinal Surgery;Sep2009, Vol. 13 Issue 9, p1593 

    Background: Peritoneal carcinomatosis (PC) is seen in about 10% of patients with colon cancer during the initial operation and has been considered a preterminal condition. The actual outcome can vary extensively depending on the presence/absence of metastases other than...

  • Sentinel node in colon cancer: a multimodal approach. Palmisano, S.; de Manzini, N.; De Pellegrin, A.; Zanconati, F. // BMC Geriatrics;2009 Supplement 1, Vol. 9, Special section p1 

    Background Colon cancer staging and prognosis are factors related to nodal status. About 15-20% stage I or II patients develop local recurrences and distant metastases within 5 years despite surgery with curative intent. Sentinel lymph node mapping aims to facilitate staging, to identify any...

  • The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. Haboubi, N. Y.; Clark, P.; Kaftan, S. M.; Schofield, P. F. // Journal of the Royal Society of Medicine;Jul1992, Vol. 85 Issue 7, p386 

    The prognosis of colorectal carcinoma relies heavily on pathological staging which includes the metastatic state of lymph nodes. Colorectal resectates from 47 patients (41 with colorectal carcinoma and six with non-malignant disease) were entered into a study to assess the best method for...

  • Can Modified Dukes' Classification be Used in Gastric Cancer Staging? ÖZgüç, Halil; Öztürk, Ersin; Kirdak, Türkay; Yercİ, ÖMer; Sönmez, Yalçın; BaǦçivan, Erol; Korun, Nusret // Turkish Journal of Medical Sciences;2006, Vol. 36 Issue 5, p271 

    Aim: Dukes' staging system is a simple system used widely in the staging of colorectal cancer. This study was designed to analyze the applicability of the modified Dukes' classification system in gastric cancer cases. Methods: The prognostic factors affecting survival in 139 gastric cancer cases...

  • Improved Lymph Node Harvest from Resected Colon Cancer Specimens Did Not Cause Upstaging from TNM Stage II to III. Storli, Kristian; Søndenaa, Karl; Furnes, Bjørg; Leh, Sabine; Nesvik, Idunn; Bru, Tore; Gudlaugsson, Einar; Bukholm, Ida; Norheim-Andersen, Solveig; Eide, Geir // World Journal of Surgery;Dec2011, Vol. 35 Issue 12, p2796 

    Background: The number of lymph nodes retrieved and examined from a resected colon cancer specimen may be crucial for correct staging. We examined if efforts to increase the lymph node harvest to more than 12 lymph nodes per specimen would upstage some patients from TNM stage II to III. Methods:...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics